目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Test Type
1.2.2. Technology
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test Type
2.2.2. Technology
2.2.3. End-use
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Endocrine Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing prevalence of the endocrine disorders
3.2.1.2. Rising demand of home health care and awareness of routine testing
3.2.1.3. Advancements in product technologies
3.2.1.4. Increasing investments in research activities for disease understanding
3.2.2. Market restraint analysis
3.2.2.1. High Cost of Advanced Endocrine Testing Devices
3.2.2.2. Lack of Awareness in Underdeveloped and Developing Countries
3.3. Endocrine Testing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pricing Analysis

Chapter 4. Endocrine Testing Market: Test Type Estimates & Trend Analysis
4.1. Test Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Endocrine Testing Market by Test Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Estradiol (E2) Test
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Follicle Stimulating Hormone (FSH) Test
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Human Chorionic Gonadotropin (hCG) Hormone Test
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Luteinizing Hormone (LH) Test
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Dehydroepiandrosterone Sulfate (DHEAS) Test
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Progesterone Test
4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7. Testosterone Test
4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.8. Thyroid Stimulating Hormone (TSH) Test
4.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.9. Prolactin Test
4.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.10. Thyroid Stimulating Hormone (TSH) Test
4.4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.11. Cortisol Test
4.4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.12. Insulin Test
4.4.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.13. Others
4.4.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Endocrine Testing Market: Technology Estimates & Trend Analysis
5.1. Technology Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Endocrine Testing Market by Technology Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Tandem Mass Spectrometry
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Immunoassay
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Monoclonal & Polyclonal Antibody Technologies
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Sensor Technology
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Clinical Chemistry
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.6. Others
5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Endocrine Testing Market: End-use Estimates & Trend Analysis
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Endocrine Testing Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Hospitals
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Commercial Laboratories
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Ambulatory Care Centers
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Others
6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Endocrine Testing Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Competitive scenario
7.5.1.3. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Competitive scenario
7.6.1.3. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Competitive scenario
7.6.8.3. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Competitive scenario
7.7.1.3. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Competitive scenario
7.7.6.3. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Competitive scenario
7.8.1.3. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Competitive scenario
7.9.1.3. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Competitive scenario
7.9.2.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Competitive scenario
7.9.3.3. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Competitive scenario
7.9.4.3. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Abbott Laboratories
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Test Type benchmarking
8.3.4.4. Strategic initiatives
8.3.5. AB Sciex
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Test Type benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Agilent Technologies Inc.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Test Type benchmarking
8.3.6.4. Strategic initiatives
8.3.7. bioMerieux SA
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Test Type benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Bio-Rad Laboratories Inc.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Test Type benchmarking
8.3.8.4. Strategic initiatives
8.3.9. DiaSorin S.p.A.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Test Type benchmarking
8.3.9.4. Strategic initiatives
8.3.10. F. Hoffmann-La Roche Ltd.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Test Type benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Laboratory Corporation of America Holdings
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Test Type benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Quest Diagnostics Incorporated
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Test Type benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Ortho Clinical Diagnostics
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Test Type benchmarking
8.3.13.4. Strategic initiatives

List of Tables
Table 1 List of abbreviation
Table 2 North America endocrine testing market, by region, 2018 - 2030 (USD Million)
Table 3 North America endocrine testing market, by test type, 2018 - 2030(USD Million)
Table 4 North America endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 5 North America endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 7 U.S. endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 8 U.S. endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 10 Canada endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 11 Canada endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 12 Europe endocrine testing market, by region, 2018 - 2030 (USD Million)
Table 13 Europe endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 14 Europe endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 15 Europe endocrine testing market, by end-u2018 - 2030 (USD Million)
Table 16 Germany endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 17 Germany endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 18 Germany endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 19 UK endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 20 UK endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 21 UK endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 22 France endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 23 France endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 24 France endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 25 Italy endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 26 Italy endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 27 Italy endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 28 Spain endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 29 Spain endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 30 Spain endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 31 Denmark endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 32 Denmark endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 33 Denmark endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 34 Sweden endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 35 Sweden endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 36 Sweden endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 37 Norway endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 38 Norway endocrine testing market, by technolog2018 - 2030 (USD Million)
Table 39 Norway endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific endocrine testing market, by region, 2018 - 2030 (USD Million)
Table 41 Asia Pacific endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 42 Asia Pacific endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 43 Asia Pacific endocrine testing market, by end-use, (USD Million) 2018 - 2030 (USD Million)
Table 44 China endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 45 China endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 46 China endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 47 Japan endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 48 Japan endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 49 Japan endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 50 India endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 51 India endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 52 India endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 53 South Korea endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 54 South Korea endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 55 South Korea endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 56 Australia endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 57 Australia endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 58 Australia endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 59 Thailand endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 60 Thailand endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 61 Thailand endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 62 Latin America endocrine testing market, by region, 2018 - 2030 (USD Million)
Table 63 Latin America endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 64 Latin America endocrine testing market, by technology, 2018 - 2030(USD Million)
Table 65 Latin America endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 66 Brazil endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 67 Brazil endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 68 Brazil endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 69 Mexico endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 70 Mexico endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 71 Mexico endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 72 Argentina endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 73 Argentina endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 74 Argentina endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 75 MEA endocrine testing market, by region, 2018 - 2030 (USD Million)
Table 76 MEA endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 77 MEA endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 78 MEA endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 79 South Africa endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 80 South Africa endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 81 South Africa endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 85 UAE endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 86 UAE endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 87 UAE endocrine testing market, by end-use, 2018 - 2030 (USD Million)
Table 88 Kuwait endocrine testing market, by test type, 2018 - 2030 (USD Million)
Table 89 Kuwait endocrine testing market, by technology, 2018 - 2030 (USD Million)
Table 90 Kuwait endocrine testing market, by end-use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Endocrine Testing market: market outlook
Fig. 14 Endocrine Testing competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Endocrine Testing market driver impact
Fig. 20 Endocrine Testing market restraint impact
Fig. 21 Endocrine Testing market strategic initiatives analysis
Fig. 22 Endocrine Testing market: Test Type movement analysis
Fig. 23 Endocrine Testing market: Test Type outlook and key takeaways
Fig. 24 Estradiol (E2) Test market estimates and forecast, 2018 - 2030
Fig. 25 Follicle Stimulating Hormone (FSH) Test market estimates and forecast, 2018 - 2030
Fig. 26 Human Chorionic Gonadotropin (hCG) Hormone Test market estimates and forecast, 2018 - 2030
Fig. 27 Luteinizing Hormone (LH) Test market estimates and forecast, 2018 - 2030
Fig. 28 Dehydroepiandrosterone Sulfate (DHEAS) Test market estimates and forecast, 2018 - 2030
Fig. 29 Progesterone Test market estimates and forecast, 2018 - 2030
Fig. 30 Testosterone Test market estimates and forecast, 2018 - 2030
Fig. 31 Thyroid Stimulating Hormone (TSH) Test market estimates and forecast, 2018 - 2030
Fig. 32 Prolactin Test market estimates and forecast, 2018 - 2030
Fig. 33 Cortisol Test market estimates and forecast, 2018 - 2030
Fig. 34 Insulin Test market estimates and forecast, 2018 - 2030
Fig. 35 Others market estimates and forecast, 2018 - 2030
Fig. 36 Endocrine Testing Market: Technology movement Analysis
Fig. 37 Endocrine Testing market: Technology outlook and key takeaways
Fig. 38 Tandem Mass Spectrometry market estimates and forecasts, 2018 - 2030
Fig. 39 Immunoassay market estimates and forecasts, 2018 - 2030
Fig. 40 Monoclonal & Polyclonal Antibody Technologies market estimates and forecasts, 2018 - 2030
Fig. 41 Sensor Technology market estimates and forecasts,2018 - 2030
Fig. 42 Clinical Chemistry market estimates and forecasts, 2018 - 2030
Fig. 43 Others market estimates and forecasts, 2018 - 2030
Fig. 44 Endocrine Testing market: End-use movement analysis
Fig. 45 Endocrine Testing market: End-use outlook and key takeaways
Fig. 46 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 47 Commercial Laboratories market estimates and forecasts,2018 - 2030
Fig. 48 Ambulatory Care Centers market estimates and forecasts, 2018 - 2030
Fig. 49 Others market estimates and forecasts, 2018 - 2030
Fig. 50 Global Endocrine Testing market: Regional movement analysis
Fig. 51 Global Endocrine Testing market: Regional outlook and key takeaways
Fig. 52 Global Endocrine Testing market share and leading players
Fig. 53 North America market share and leading players
Fig. 54 Europe market share and leading players
Fig. 55 Asia Pacific market share and leading players
Fig. 56 Latin America market share and leading players
Fig. 57 Middle East & Africa market share and leading players
Fig. 58 North America, by country
Fig. 59 North America market estimates and forecasts, 2018 - 2030
Fig. 60 U.S. market estimates and forecasts, 2018 - 2030
Fig. 61 Canada market estimates and forecasts, 2018 - 2030
Fig. 62 Europe market estimates and forecasts, 2018 - 2030
Fig. 63 UK market estimates and forecasts, 2018 - 2030
Fig. 64 Germany market estimates and forecasts, 2018 - 2030
Fig. 65 France market estimates and forecasts, 2018 - 2030
Fig. 66 Italy market estimates and forecasts, 2018 - 2030
Fig. 67 Spain market estimates and forecasts, 2018 - 2030
Fig. 68 Denmark market estimates and forecasts, 2018 - 2030
Fig. 69 Sweden market estimates and forecasts, 2018 - 2030
Fig. 70 Norway market estimates and forecasts, 2018 - 2030
Fig. 71 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 72 China market estimates and forecasts, 2018 - 2030
Fig. 73 Japan market estimates and forecasts, 2018 - 2030
Fig. 74 India market estimates and forecasts, 2018 - 2030
Fig. 75 Thailand market estimates and forecasts, 2018 - 2030
Fig. 76 South Korea market estimates and forecasts, 2018 - 2030
Fig. 77 Australia market estimates and forecasts, 2018 - 2030
Fig. 78 Latin America market estimates and forecasts, 2018 - 2030
Fig. 79 Brazil market estimates and forecasts, 2018 - 2030
Fig. 80 Mexico market estimates and forecasts, 2018 - 2030
Fig. 81 Argentina market estimates and forecasts, 2018 - 2030
Fig. 82 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 83 South Africa market estimates and forecasts, 2018 - 2030
Fig. 84 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 85 UAE market estimates and forecasts, 2018 - 2030
Fig. 86 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 87 Market share of key market players - Endocrine Testing market